Atherosclerosis is the major cause of death in patients with diabetes. Lowdensity lipoprotein (LDL) being the most important cholesterol-carrying lipoprotein has been studied extensively in both diabetes and non-diabetes. This paper reviews the literature but also focuses on the precursors of LDL an
Diabetes and Atherosclerosis—a Lipoprotein Perspective
✍ Scribed by G. Steiner
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 156 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0742-3071
No coin nor oath required. For personal study only.
✦ Synopsis
Atherosclerosis is the most frequent complication of diabetes. It affects all major vascular beds. The metabolic derangements that occur in diabetes may underlie many of the reasons for this. These abnormalities include alterations in the metabolism of lipoproteins, particularly the triglyceride-rich lipoproteins. Studies are currently being conducted to determine whether correcting the dyslipoproteinaemias associated with diabetes will reduce the risk of atherosclerosis in the diabetic population.
📜 SIMILAR VOLUMES
Atherosclerosis is a chronic disease which involves the build up of cholesterol and fatty deposits within the arterial wall. This results in the narrowing of the vessel lumen, which eventually restricts blood flow to vital organs such as the heart and lungs. These events may culminate in a heart att
The primary objective of the Diabetes Atherosclerosis Intervention Study (DAIS) is to determine by quantitative coronary angiography whether long-term correction of the dyslipoproteinemia of diabetes with micronized fenofibrate results in evidence of decreased progression or regression of angiograph
This study evaluated the serum concentrations of lipids, lipoproteins, apolipoproteins, and high-density lipoprotein (HDL) subfractions in Brazilian adults. We analyzed the distribution of lipids in HDL 2 and HDL 3 in a normolipidemic population without evidence of established cardiovascular disease